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Background: The skin is highly predisposed to injury because of its direct contact with the environment. The aim of 
treating of wounds is to both hasten healing, and to minimise the occurrence of perturbations of the healing process. 
Many plants traditionally used to treat wounds have been proven to support the healing process using scientific 
models. Aspilia pluriseta has been used by a number of communities in East and Southern Africa to treat wounds.  
Objectives: This study aimed at testing ethnomedical claims of wound healing activity of A. pluriseta using preclinical 
models.  
Methods: Aerial parts of the plant were ground and incorporated into an ointment base (10% and 20% w/w) to 
evaluate the influence of the plant on the healing of acute excision wounds in mice compared to Silverex Cream® and 
Simple Ointment (B.P.). The 20% ointment was tested for skin sensitization in guinea pigs. 
Results: The effects of the plant-based ointments on wound contraction and gross epithelialisation time were less 
than significantly different from the controls (p≥0.05), but histopathologic examination revealed remarkable 
epithelialisation and collagen deposition in the wounds treated with the these ointments. The 20% A. pluriseta-based 
ointment induced moderate allergic contact dermatitis.  
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1. Introduction 
A wound is an injury that results from the disruption of 
the normal tissue anatomy and function. It may result in 
a break of the epithelium with or without loss of 
underlying connective tissue. Wounds may result from 
physical, chemical, microbial agents or immunological 
mechanisms (Raina et al, 2008). Wound healing is the 
process through which the wound tissue is restored as 
closely as possible to its pre-injury state and is the 
result of interaction between cells, blood and 
connective tissue components directed by growth 
factors and cytokines. It is characterized by three major 
phases, inflammation, proliferation and remodelling 
which are distinct but overlap in time (Singer and Clark 
1999). Cutaneous wounds primarily heal by three 
mechanisms: connective tissue matrix deposition, 
contraction and epithelialisation (Diegelmann and 
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Evans 2004). The primary objective in the treatment of 
wounds is to hasten wound closure and to achieve a 
functional and cosmetic scar (Singer and Clark 1999).  
When a wound results, the possible outcomes are 
normal healing, excessive healing or deficient healing. 
Normal wound healing is the typical repair response, 
while excessive or deficient healing is considered a 
pathologic response (Diegelmann and Evans 2004). 
Dermal wounds primarily heal by deposition of a 
connective tissue matrix, contraction and 
epithelialisation (Diegelmann and Evans 2004). 
Wounds with regular margins, for instance surgically 
created wounds, whose margins are then brought in 
close apposition for example by use of staples or 
sutures, heal by primary intention. This involves the 
deposition of connective tissue ground substance and 
connective tissue matrix. Wounds that remain open heal 
by contraction. This is postulated to be the result of the 
activity of contractile fibroblasts (myo-fibroblasts) 
(Tomasek et al, 2002). 
The primary goal in the treatment of wounds is to 
hasten their closure and to achieve a functional and 
aesthetically acceptable scar (Singer and Clark 1999). 
The ‘ideal’ wound healing agent should facilitate 
granulation, enhance immunity, aid in debridement, 
control infection, reduce pain and discomfort and 
promote angiogenesis and perfusion  (Gilchrist 1994). It 
should also be affordable, easy to both apply and 
remove, and cause minimal patient discomfort (Nilesh 
Gupta 2010). The complexity of the wound healing 
process has acted as a hindrance to the development of 
modern pharmacological agents that augment healing 
(Pierce and Mustoe 1995). Some alternative therapies, 
particularly herbal products have been claimed to 
closely approximate the ideal wound healing agent 
(Nilesh Gupta 2010). In addition to this, herbal wound 
healing products are cheaper than conventional 
counterparts, purportedly safer and elicit fewer 
hypersensitivity reactions (Nilesh Gupta 2010). In vivo 
models of wound healing have been used to test and 
confirm the wound healing activity of many plants that 
are reported in ethnomedical/ethnobotanical surveys 
to have been used to treat wounds (Ayyanar and 
Ignacimuthu 2009). 
Aspilia pluriseta, commonly known as dwarf aspilia is a 
perennial, woody herb with multiple branches from a 
woody rootstock and with yellow flower-heads. It is a 
plant of open woodland and grassland, especially areas 
with black cotton soils (Gachathi 2007). It is native to 
areas of East, Central and Southern Africa in an altitude 
range between 1360 and 1560 meters above sea level. 
The plant has a number of documented ethnomedical 
uses in Kenya, including the treatment of wounds and 
pimples (Gachathi 2007; Njoroge and Bussmann 2007), 
coughing and otitis media (Njoroge and Bussmann 
2006), eye conditions (Gachathi 2007) and Diabetes 
Mellitus (Piero and N Joan 2011). 
The primary objective of this study was informed by the 
need for pharmacological and toxicological testing of 
traditional remedies before recommending them for 
therapy (Nilesh Gupta 2010; Midiwo et al, 2001). We 
evaluated the effects of the ointment containing 
powdered aerial parts of A. pluriseta on selected 
processes of excision wound healing and dermal safety, 
specifically allergy induction. 
2. Materials and Methods 
2.1 Plant material 
Aspilia pluriseta aerial parts (stems, leaves and flower 
heads) were collected in Ruiru, Kiambu County in the 
month of January, 2012. The identity of the plant was 
confirmed by the East Africa Herbarium where a 
voucher specimen was deposited (Voucher no: 
Kuria/Asp/001). The plant material was cleaned with 
tap water and then dried in the shade for 10 days, then 
ground using an electric mill. 
2.2 Preparation of the ointments 
The powdered A. pluriseta was triturated into an 
ointment base (Simple Ointment B.P) to form a 10% and 
20% (w/w) A. pluriseta ointment for testing. 
2.3 Excision wound healing assay 
Four month old, male, Swiss Albino mice were 
purchased from the Kenya Agricultural Research 
Institute (KARI) Trypanosomiasis Research Centre. The 
animals were allowed 7 days to acclimatize to 
conditions at the animal house in the Department of 
Public Health, Pharmacology and Toxicology, University 
of Nairobi. They were fed standard pelleted feed (Unga 
Mice Pencils, Unga Feeds) and water ad libitum. 
The excision model was used to provide information on 
wound contraction, epithelialisation and histologic data. 
The backs of the mice were shaved using an electric 
clipper. The shaved area was disinfected using povidone 
iodine.  A square area, approximately 100mm² was 
marked on the dorsum using a stencil. Full thickness 
excision wounds were created using thumb forceps and 
scissors along the edges of the marked areas (Yadav et 
al, 2014). The excision wounds were created with the 
mice under halothane anaesthesia. The mice were then 
randomly divided into four groups each having eight 
members. The first two groups were treated with the 
10% and 20% A. pluriseta ointment. The third group 
was treated with the vehicle ointment (Simple Ointment 
B.P.) and acted as the negative control group. The fourth 
group was treated with a standard wound drug, Silverex 
Cream® (Ranbaxy) containing 1% silver sulfadiazine. 
The wounds were left open (Süntar et al, 2011) and 
treated once daily for 21 days. Before the application of 
the respective treatment, the wounds were cleaned with 
antiseptic solution. The wounds were observed daily 
over the test duration. Any hair growing over the 
wound area was trimmed to facilitate observation. The 
time it took for each wound to be fully covered by an 
epithelium (time when the scab fell off without leaving a 
raw area) was recorded for each animal.  The wounds 
margins were traced onto tracing paper for area 
determination after wound creation. Wound areas were 
estimated by the use of 1mm2 graph paper(Yadav et al, 
2014). Wound contraction was tracked by determining 
the wound area every three days until the wounds were 
fully re-epithelialised grossly. Wound contraction was 
calculated as percent reduction of wound area relative 
to the initial wound area on the day of wounding (initial 
wound area = 100%). 
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On the 7th and 14th days, a representative animal from 
each group was sacrificed and a biopsy of the wound 
harvested for histology. On the 21st day, all the animals 
were euthanized using halothane and histopathology 
samples were harvested from all the animals. The 
harvested samples were fixed in 10% formalin, 
processed routinely and blocked with paraffin wax. 
Serial sections, 5µm thick were cut with a microtome 
and then stained with Hematoxylin and Eosin and 
Masson’s Trichrome (Nisbet et al, 2010). The stained 
sections were examined using a light microscope. The 
selected histologic parameters (neutrophil population, 
macrophage population, fibroblast population, collaged 
deposition, vascularisation and epithelialisation) were 
evaluated qualitatively and scored into three categories, 
+, ++ and +++, representing increasing magnitude of 
each respective parameter. 
2.4 Skin sensitization assay  
This was carried out along OECD Test Guideline 406 
(Buehler Non-adjuvant test method) (OECD 1992) with 
modifications on the number of animals and the use of 
an occlusive patch. 3 female adult (3 months old) albino 
guinea pigs were used. A 4cm2 square area was marked 
on the right posterior flank which was earlier shaved, 
about 1cm from the dorsal midline and a film of the 
20% A. pluriseta ointment was applied on it. This 
application was repeated on the 7th and 14th days and 
constituted the induction phase of the trial. On the 28th 
day, the left side, equally shaved and marked was used 
for challenge phase. 
Six hours after the application of the ointment on the 
new site, the residual ointment was wiped off using 
moist cotton wool. 24 hours later, the site was observed 
for a skin reaction, and the lesions scored. Challenge 
exposure was repeated again on the left side on the 35th 
day to confirm the observations made on after the first 
challenge exposure. 
2.5 Data analysis 
Means (±SEM) were computed for measures of wound 
contraction and epithelialisation times. The means for 
the four treatment groups were compared with each 
other using one-way Analysis of Variance (ANOVA). P 
values ≤0.05 were considered significant. The histology 
and skin sensitization data were not subjected to 
statistical analysis. 
2.6 Ethical considerations 
The animals used in these assays were handled 
humanely at all times in accordance with animal care 
and use guidelines of the University of Nairobi and 
other applicable guidelines and regulations. 
3.  Results 
3.1 Epithelialisation time 
The 20% A. pluriseta treated group took less time than 
the other groups to fully epithelialise as shown in 
Figure 1. The difference in the mean epithelialisation 
time was however not statistically significant. 
 
Figure 1: Graph showing the epithelialisation time (mean number of days ± SEM (standard error of mean)) for the 
different treatments from left to right: 10% A pluriseta ointment, 20% A pluriseta ointment, Simple Ointment 
(negative control) and Silverex Cream (reference drug). 
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Figure 2: Graph showing the wound contraction rates for the different groups (percent wound area reduction ± SEM) 
 
The collagen (green in colour) in image A is sparse and disorganized; that in image B is densely laid down and oriented in a general 
direction, similar to but more than is seen in image C. Also, the neo-epidermis (red in colour) in image B is compact and there is little 
dilineation between individual cells as opposed to images A and C. 
Figure 3: Photomicrographs showing comparison of extent of collagen lay-down and epithelialisation between the 
Simple Ointment B.P. (negative control) (A), the 10% Aspilia pluriseta ointment (B) and the Silverex Cream® 
(standard drug) (C) groups (Day 21, ×400, Masson’s Trichrome stain).  
 
3.2 Wound contraction 
The 20% A. pluriseta ointment showed marginally 
higher contraction (assessed as percent wound area 
reduction) towards the end of the first week and during 
the second week of healing. However, the difference in 
wound contraction rates between the test and the 
control groups was not statistically significant. All the 
wounds were fully closed (100% wound area 
reduction) on day 21. The wound contraction results 
are shown in Figure 2. 
3.3 Histology  
In the first week of healing, the wounds that were 
treated with the A. pluriseta ointments had intensive 
granulation as opposed to the negative control group 
which had thinly deposited granulation tissue. Also, the 
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A. pluriseta ointment and the standard drug treated 
wounds had more mature fibroblasts than the negative 
control group. On Day 14 of healing, all the wounds 
except those treated with the 20% A. pluriseta ointment 
had haemorrhage. The A. pluriseta ointment treated 
wounds had more collagen, comparable to the standard 
drug treated wounds and more than the negative 
control group.  At the end of the experiment on the 21st 
day, the A. pluriseta ointment treated wounds had fully 
epithelialised. They also had abundant collagen and a 
diminished number of blood capillaries. The histology 
results are summarised in Table 1 and Figure 3. 
3.4 Skin sensitization 
The 20% A. pluriseta ointment induced moderate 
allergic reaction after the challenge exposure on the 28th 
day which was indicated by a confluent erythema on the 
skin area used for challenge exposure. The erythema 
persisted for approximately 48 hours and then resolved 
on its own. This exposure was repeated 7 days later (35 
days after the first application) to confirm the results 
obtained, and similar observations were made. 
 
 Table 1: Summary of the histological observations 
Parameter Group 
Day/Score 
Day 7 Day 14 Day 21 
Neutrophils 10% A pluriseta +++ +++ + 
20% A pluriseta +++ ++ + 
Simple ointment +++ +++ + 
Silverex® Cream ++ +++ + 
Macrophages  10% A pluriseta + ++ ++ 
20% A pluriseta + ++ + 
Simple ointment + ++ ++ 
Silverex® Cream ++ ++ ++ 
Fibroblasts 10% A pluriseta + + +++ 
20% A pluriseta + ++ +++ 
Simple ointment + + + 
Silverex® Cream + ++ +++ 
Collagen 10% A pluriseta + + ++ 
20% A pluriseta + ++ +++ 
Simple ointment + + ++ 
Silverex® Cream + ++ +++ 
Vascularisation 10% A pluriseta +++ ++ ++ 
20% A pluriseta +++ ++ + 
Simple ointment ++ ++ +++ 
Silverex® Cream +++ +++ ++ 
Epithelialisation 10% A pluriseta + + ++ 
20% A pluriseta + + +++ 
Simple ointment + + ++ 
Silverex® Cream + + +++ 
 
4. Discussion 
Aspilia pluriseta at 10% and 20% concentration in 
simple ointment was observed to have an effect on the 
contraction, granulation and epithelialisation of 
excision wounds in a mouse model. It also induced 
allergic dermatitis in guinea pigs as evidenced by 
development of erythema on repeated application. The 
observed effects on the process of wound healing are in 
agreement with the observations made in similar 
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studies on the wound healing activity of plants (Yadav 
et al, 2014). The wound healing activity is similar to that 
reported by Okoli, Akah, and Okoli (2007) who reported 
enhancement of epithelialisation of excision wounds by 
the methanol extract of Aspilia africana, a member of 
the same genus as the test plant, A. pluriseta. The extent 
to which Aspilia pluriseta promoted wound contraction 
and gross epithelialisation was less than significantly 
different from the controls, as opposed to the measures 
of the same parameters in like studies. This observation 
may be explained by the fact that in this study, whole 
plant material was used as opposed to aqueous and 
organic solvent extracts from plant tissue in other 
studies. The allergy inducing activity is in agreement 
with the findings of other studies, that plants in family 
Asteraceae (formerly Compositae) readily induce 
allergic contact dermatitis due to sesquiterpene 
lactones in these plants’ tissues (Jovanović and Poljacki 
2003).   
The observed activity of Aspilia pluriseta on wounds is 
in agreement with other studies on the effect of 
medicinal plants in the healing of wounds. The wound 
healing enhancement that was observed in this project 
is similar to that seen in other experiments on in vivo 
support of wound healing by plant extracts (Kumar et 
al, 2007).  
The findings of this study point to a multi-pronged 
enhancement of healing by A. pluriseta ointments. The 
plant material supported early polymorphonuclear 
inflammation, while at the same time allowing the 
recruitment of wound macrophages. It also induced or 
supported an early intensive granulation with 
numerous and more mature fibroblasts. Moreover, the 
plant-based ointments seemed to enhance collagen 
synthesis and deposition. Sections from groups treated 
with the ointments were more fibrotic than those from 
the control groups. Also, the A. pluriseta ointments 
promoted more epidermal remodelling. 
5. Conclusion 
In view of these observations, we confirm the wound 
healing activity of A. pluriseta reported ethnomedically. 
Further research is needed to determine the exact 
mechanism of action of the plant in the healing process 
of wounds. Development of a drug for treating acute 
wounds from the plant should be explored. The 
allergenic potential of the plant should be borne in mind 
during use of the plant or products derived from it. 
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